Home › Funds › Ally Bridge Group (NY) LLC › CTMX

Ally Bridge Group (NY) LLC position in CTMX

CYTOMX THERAPEUTICS INC. · Health Care

Ally Bridge Group (NY) LLC reported holding 775,000 shares of CTMX (CYTOMX THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$2.9M, representing 2.57% of its reported portfolio and ranking #12 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed CTMX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)775.00K sh
Reported value held$2.91M
Portfolio Weight2.57%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ally Bridge Group (NY) LLC's CTMX position evolved

Ally Bridge Group (NY) LLC first disclosed a stake in CTMX in Q1 2026 at 900,000 shares (US$4.2M). Across 2 filings, Ally Bridge Group (NY) LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 775,000 shares valued at US$2.9M — a reduction of -125,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 900.00K $4.23M New
Q2 2026 775.00K $2.91M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CTMX and 13F data

CTMX (CYTOMX THERAPEUTICS INC.) is a Health Care company. 45 other funds we track also report a position in CTMX — the largest reported positions include Kynam Capital Management, LP (US$81.4M), PERCEPTIVE ADVISORS LLC (US$39.1M), Venrock Adviser, LLC (US$18.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CTMX

All CTMX fund holders →

FAQ

How long has Ally Bridge Group (NY) LLC held CTMX?

Ally Bridge Group (NY) LLC has disclosed CTMX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Ally Bridge Group (NY) LLC's current position in CTMX?

As of Q2 2026, Ally Bridge Group (NY) LLC holds 775.00K shares of CTMX (CYTOMX THERAPEUTICS INC.), valued at $2.91M, representing 2.57% of its reported portfolio and ranking #12.

Has Ally Bridge Group (NY) LLC been buying or selling CTMX?

In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC reduced its position in CTMX.

Which other funds hold CTMX?

Other major institutional holders of CTMX include Kynam Capital Management, LP, PERCEPTIVE ADVISORS LLC, Venrock Adviser, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.